Literature DB >> 29943187

Diagnosis of Recurrent Fracture in a Pediatric Cohort.

M Fiscaletti1,2, C P Coorey3, A Biggin4,3, J Briody5, D G Little3,6,7, A Schindeler3,7, C F Munns4,3.   

Abstract

Significant fracture history in children is defined as having at least one vertebral fracture, at least 2 fractures by age 10, or at least 3 fractures by age 19. Between September 2011 and December 2014, clinical data were collected on children with a significant fracture history that attended a major Australian children's hospital. Fifty-six patients were identified as having 305 fractures in total, including 44 vertebral fractures. 18% of patients (10/56) were diagnosed with osteogenesis imperfecta (OI) by a bone health expert, molecular testing or both, and they sustained 23% of all fractures (71/305). Analysis of serum bone biochemistry showed all median values to be within a normal range and no clinically significant differences between patients with and without OI. The DXA and pQCT derived bone mineral density (BMD) and bone mineral content (BMC) Z scores were reduced overall. DXA derived total body and lumbar spine areal BMD-for-age and BMC-for-age Z scores were significantly lower in children who had vertebral fractures or who were later diagnosed with OI. Similarly, pQCT performed on radii and tibiae showed Z scores significantly less than zero. pQCT-derived limb muscle cross sectional area Z scores were significantly lower in the OI subgroup. In conclusion, this study describes the bone phenotype of children referred to a tertiary hospital clinic for recurrent fractures and highlights a subset of children with previously undiagnosed OI, but a larger cohort without classic OI. Thus it can be clinically challenging to differentiate between children with OI type 1 (mild phenotype) and non-OI children without bone densitometry and genetic testing. We conclude that recurrent fractures in children should prompt a comprehensive bone and systemic health assessment to eliminate an underlying pathology.

Entities:  

Keywords:  Bone; Bone density; Bone mineral density; DXA; Dual-energy X-ray absorptiometry; Fracture; Osteogenesis imperfecta; Peripheral quantitative computed tomography; Recurrent fracture; pQCT

Mesh:

Year:  2018        PMID: 29943187     DOI: 10.1007/s00223-018-0449-6

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  7 in total

1.  Skeletal fragility: an emerging complication of Ehlers-Danlos syndrome.

Authors:  Anna Maria Formenti; Mauro Doga; Stefano Frara; Marco Ritelli; Marina Colombi; Giuseppe Banfi; Andrea Giustina
Journal:  Endocrine       Date:  2018-12-15       Impact factor: 3.633

Review 2.  Drug Treatment of Low Bone Mass and Other Bone Conditions in Pediatric Patients.

Authors:  Stefania Costi; Teresa Giani; Francesco Orsini; Rolando Cimaz
Journal:  Paediatr Drugs       Date:  2022-01-11       Impact factor: 3.022

3.  A Contemporary View of the Definition and Diagnosis of Osteoporosis in Children and Adolescents.

Authors:  Leanne M Ward; David R Weber; Craig F Munns; Wolfgang Högler; Babette S Zemel
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

Review 4.  Osteogenesis Imperfecta: New Perspectives From Clinical and Translational Research.

Authors:  Josephine T Tauer; Marie-Eve Robinson; Frank Rauch
Journal:  JBMR Plus       Date:  2019-02-20

5.  Characterisation of peripheral bone mineral density in youth at risk of secondary osteoporosis - a preliminary insight.

Authors:  Mark Jenkins; Nicolas H Hart; Sophia Nimphius; Paola Chivers; Timo Rantalainen; Karen M Rothacker; Belinda R Beck; Benjamin K Weeks; Fleur McIntyre; Beth Hands; Brendan P Beeson; Aris Siafarikas
Journal:  J Musculoskelet Neuronal Interact       Date:  2020-03-03       Impact factor: 2.041

Review 6.  Glucocorticoid-Induced Osteoporosis: Why Kids Are Different.

Authors:  Leanne M Ward
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-16       Impact factor: 5.555

Review 7.  Part I: Which Child with a Chronic Disease Needs Bone Health Monitoring?

Authors:  Leanne M Ward
Journal:  Curr Osteoporos Rep       Date:  2021-07-10       Impact factor: 5.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.